$279.00
Ultra-advanced combination of triple-agonist Retatrutide with amylin analog Cagrilintide. Targets four metabolic receptor pathways simultaneously — GIP, GLP-1, glucagon, and amylin.
Phorm Labs
Research Areas
10 mg
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
No products in the cart.
Reviews
There are no reviews yet.